Immune biomarkers are more accurate in prediction of survival in ulcerated than in non-ulcerated primary melanomas Article

de Moll, Ellen H, Fu, Yichun, Qian, Yingzhi et al. (2015). Immune biomarkers are more accurate in prediction of survival in ulcerated than in non-ulcerated primary melanomas . Cancer Immunology, Immunotherapy, 64(9), 1193-1203. 10.1007/s00262-015-1726-0

Open Access

cited authors

  • de Moll, Ellen H; Fu, Yichun; Qian, Yingzhi; Perkins, Sara H; Wieder, Shira; Gnjatic, Sacha; Remark, Romain; Bernardo, Sebastian G; Moskalenko, Marina; Yao, Jonathan; Ferringer, Tammie; Chang, Rui; Chipuk, Jerry; Horst, Basil A; Birge, Miriam B; Phelps, Robert G; Saenger, Yvonne M

sustainable development goals

authors

publication date

  • September 1, 2015

published in

keywords

  • AMERICAN JOINT COMMITTEE
  • Biomarker
  • CANCER
  • CD2
  • DISEASE PROGRESSION
  • EORTC 18991
  • Immunology
  • Life Sciences & Biomedicine
  • Melanoma
  • Oncology
  • PATIENT SURVIVAL
  • PRIMARY CUTANEOUS MELANOMA
  • PROGNOSTIC-SIGNIFICANCE
  • STAGE
  • Science & Technology
  • T-CELL-ACTIVATION
  • TUMOR-INFILTRATING LYMPHOCYTES
  • Tumor-infiltrating lymphocytes
  • Ulceration

Digital Object Identifier (DOI)

publisher

  • SPRINGER

start page

  • 1193

end page

  • 1203

volume

  • 64

issue

  • 9